OTC naloxone is a baby step toward making the life-saving medication accessible
Critiquing profiteering by naloxone manufacturers and proposing solutions to fix this issue.
Check out our recent Journal of Addiction Medicine invited commentary
Emphasizing cost-effective strategies is crucial to prevent the misuse of opioid settlement funds
Understanding processes to report opioid settlement waste, fraud, abuse, & mismanagement to the AG
FOR IMMEDIATE RELEASE Date: May 2, 2025 Well, folks, pack it up. Turn off the lights, shred the research papers (save it for confetti though!), and cancel that subscription – the Opioid Policy Institute is officially closing, effective immediately. We’re closing because the laser-focused efforts by President Donald J. Trump